Pfizer’s New RSV Vaccine to Protect Infants Just Received FDA Approval
Pfizer’s New RSV Vaccine to Protect Infants Just Received FDA Approval In a significant development, Pfizer announced today that its promising new respiratory syncytial virus (RSV) vaccine has acquired approval from the U.S. Food and Drug Administration (FDA) for protecting infants against this common respiratory virus that poses a severe threat to…